Isothermal Nucleic Acid Amplification Technology/INAAT Market by Product (Assay & Kit, System), Application (Infectious disease [HIV, Influenza], Blood Screening), Type (LAMP, SDA, NASBA, HDA), End User, Region – Global Forecast to 2024

2020-01-16
Price :
Published : Jan-2020
No. of Pages : 215

“The rising prevalence of infectious diseases and the introduction of newer pathogens, and the cost-benefits of INAAT is expected to drive the overall growth of the INAAT market”

The global isothermal nucleic acid amplification technology (INAAT) market size is expected to grow from USD 1.9 billion in 2019to USD 3.3 billion by 2024, at a CAGR of 11.0% during the forecast period. The major factors driving the growth of this market include the rising prevalence of infectious diseases and the introduction of newer pathogens, the need for prompt diagnosis, the increasing number of blood transfusions and donations, and the cost-benefits of INAAT. However, the extensive usage and reliance on PCR are expected to limit the adoption of INAAT.

“Assay, kits and reagents segment is expected to grow at the highest CAGR during the forecast period”

Based on the product, the market is segmented broadly into assay, kits, and reagents, and systems. The assay, kits, and reagents segment is projected to grow at the highest CAGR during the forecast period. The increasing number of infectious disease diagnostic tests carried out; the rising prevalence of infectious diseases; the continuous launch of newer, faster, and more reliable POC products; increasing approvals of CLIA-waived tests; accessibility to a wide range of reagents; repeated purchase of reagents; and the increasing use of reagents in therapeutics, basic research, and assay development.

“TMA is expected to grow at CAGR during the forecast period”

Based on type, the INAAT market is segmented into TMA, LAMP, SDA, HDA, NASBA, and other INAAT technologies. The TMA segment is expected to be the fastest-growing segment during the forecast period due to the growing reliance on POC diagnosis in hospitals and blood banks.

“Infectious disease diagnosis segment to grow at the highest CAGR during the forecast period.”

The INAAT market, by the applications, has been categorized into infectious disease diagnosis, blood screening, and other applications (cancer diagnosis, cancer research, and laboratory research, which encompass cDNA preparation, whole-genome amplification (WGA), single-nucleotide polymorphism (SNP), and mutation analysis).Infectious disease diagnosis segment to grow at the highest CAGR during the forecast period owing to the increasing number of infectious disease diagnostic tests carried out and rising prevalence of infectious diseases, among others.

“Asia Pacific region to account for the largest share of the global INAAT market in 2019.”

Asia Pacific is expected to be the fastest-growing segment during the forecast period. Factors such as the sustained economic growth in several Asia Pacific countries, the rising disposable income, healthcare infrastructure modernization, increasing penetration of cutting-edge diagnostic technologies (including INAAT) for research and clinical applications, high infectious disease burden, availability of low-cost POC INAAT assays, and growing awareness among physicians and healthcare professionals about the benefits of gene-based disease diagnosis and treatment in Asia Pacific countries are expected to support market growth in this region during the forecast period.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the INAAT market.

  • By Respondent Type: Supply Side: 80%, Demand Side: 20%
  • By Designation: C-level Executives: 25%, Directors: 18%, and Others: 57%
  • By Region: North America: 50%, Europe: 20%, APAC: 20%, and RoW: 10%

The INAAT market comprises major players such as Grifols S.A. (Spain), Hologic, Inc. (US), Abbott Laboratories, Inc. (US), Becton, Dickinson & Company (US), and Meridian Bioscience (US).The study includes an in-depth competitive analysis of these key players in the INAAT market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:

The study covers the INAAT market across various segments. It aims at estimating the market size and the growth potential of this market across different segments based on the product, type, application, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall INAAT market and its sub segments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, and opportunities.

Filed in: Biotechnology
Publisher : marketsandmarkets
More Reports
Title Price Buy Now

Mice Model Market by Mice Type (Inbred, Knockout), Technology (CRISPR, TALEN, ZFN), Application (Oncology, Diabetes, Immunology), Service (Breeding, Cryopreservation, Genetic testing), Care Products (Cages, Bedding, Feed), Region – Global Forecast to 2025

“Increasing implication of mouse clinical trials (MCTs) and ongoing innovation in mice models are set to drive the mice model market.’’ The global mice model market size is projected to reach USD 1.9 billion by 2025 from USD 1.4 billion in 2020, at a CAGR of 6.4% during the forecast period. The major factors driving the growth of this market are the Growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increasing implications of mouse clinical trials (MCTs) for more predictive outcomes and ongoing innovations in mice models are driving the growth of the global mice model industry. However, Implementation of laws and regulations for animal protection and welfare has enforced restrictive practices and bans on the use of animals for different purposes th......
$4950

Drug Discovery Services Market by Process (Target Selection, Validation, Lead Optimization), Type (Medicinal Chemistry, DMPK), Drug Type (Biologics, Small Molecules), Therapeutic (Oncology, Neurology), Company (Tier 1, 2, 3) – Global Forecast to 2025

“Increasing R&D spending and initiatives for rare disease and orphan drugs research are set to drive the drug discovery services market.’’ The drug discovery services market is projected to reach USD 21.4 billion by 2025 from USD 11.1 billion in 2020, at a CAGR of 14.0% during the forecast period. The major factors driving the growth of this market are the growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increasing demand for outsourcing analytical testing and clinical trial services, initiatives for research on rare diseases and orphan drugs, and focus on drug discovery. However, the high cost of drug discovery and development and stringent regulations governing drug discovery and animal usage in testing may restrict the growth of this marke......
$4950

Label-free Detection Market by Product & Service (Instruments, Consumables (Biosensor Chip), Software), Technology (Surface Plasmon Resonance), Application (Binding Kinetics), End User (Pharmaceutical & Biotechnology Companies) – Global Forecast to 2025

“Introduction of technologically advanced products, and a growing number of drug discovery programs through academic-industrial partnerships are set to drive the label-free detection market.’’ The global label-free detection market size is estimated to be USD 431 million in 2020 and projected to reach USD 626 million by 2025, at a CAGR of 7.7%. Growth in this market is largely driven by the introduction of technologically advanced products, a growing number of drug discovery programs through academic-industrial partnerships, and the high sensitivity of label-free technologies. “By consumables type segment, the biosensor chips accounted for the fastest growing consumable segment of the label-free detection market” On the basis of product & service type, the consumable......
$4950

In Vitro Toxicity Testing Market by Product (Assay (Western Blot, Tissue Culture),Equipment, Assay Reagent, Software), Toxicity Endpoints (ADME, Skin Irritation, Corrosion),Industry (Pharmaceutical, Cosmetics)-COVID-19 Impact – Global Forecast to 2025

“The global in vitro toxicology testing market is projected to grow at a CAGR of 10.3%.” The in vitro toxicology testing market is expected to reach USD 14.9 billion by 2025 from an estimated USD 9.1 billion in 2020, at a CAGR of 10.3%. The opposition to animal testing, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development are the primary growth factors for this market. The increasing focus of the pharmaceutical and cosmetics industries on using in vitro methods for product testing along with the improving in silico methods for predictive toxicology studies are expected to offer significant growth opportunities for players in this market. However, the dearth of skilled professionals is a major market challenge. ......
$4950

In Situ Hybridization (ISH) Market by Product (Consumables (Kits, Probes) Software), Technology (FISH (DNA, RNA), CISH), Application (Cancer, Infectious Disease), and End User (Diagnostic Labs, Research Institutes, CROs), Region – Global Forecast to 2025

“Increasing incidence of genetic disorders and  ISH based companion diagnostics tests are set to drive the ISH market.’’ The global in situ hybridization (ISH) market size is projected to reach USD 1.3 billion by 2025 from USD 0.9 billion in 2020, at a CAGR of 7.4% during the forecast period. The increasing incidence of cancer and awareness of companion diagnostics test are the major factors driving the growth of this market. However, the lack of skilled professionals poses a challenge to ISH market. “By consumables type, the kits & reagents accounted for the fastest-growing segment of the ISH market.” The kits & reagents segment accounted for the largest share of this market in 2019. The rise in government and private funding in life sciences and cancer researc......
$4950

Sterile Filtration Market by Product (Cartridge, Capsule, Syringe), Application (Fill Finish Process, Bioburden Reduction), Membrane (Nylon, PTFE, PES, PVDF), Pore Size (0.2 Microns), End User (Pharmaceutical, Biotechnology, F&B) – Global Forecast to 2025

“Sterile filtration  market to register a CAGR of 8.2% from 2020 to 2025.” The global sterile filtration  market size is projected to reach USD 7.6 billion by 2025 from USD 5.1 billion in 2020, at a CAGR of 8.2% during the forecast period. The growing demand for pure water in the end-user market, increasing adoption of single-use technologies, and rising focus on the development of large biopharmaceutical drugsdriving the growth of the sterile filtration . “Atherectomy devices accounted for the larger share of the plaque modification devices market in 2019.” Based on type, the plaque modification devices market is segmented into atherectomy and thrombectomy. In 2019, the atherectomy devices segment accounted for the larger market share, mainly due to the increasing incid......
$4950

Immunohistochemistry (IHC) Market by Product (Antibodies, Reagents (Chromogenic Substrates), Kits), Application (Diagnostics (Cancer, Infectious), Research, Forensic), End User (Hospitals, Diagnostic Laboratories, Academic) – Global Forecast to 2025

“Increasing incidence of chronic diseases, and  technological advancements in IHC are set to drive the IHC market.’’ The global immunohistochemistry market is projected to reach USD 2.7 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 6.6% during the forecast period. The increasing incidence and prevalence of cancer, technological advancements in IHC, and the availability of reimbursement for IHC tests are the major factors driving the growth of this market. However, the high degree of consolidation is expected to restrain the growth of this market during the forecast period “By antibodies type, the primary antibodies accounted for the fasted growing antibody segment of the IHC  market” The antibodies segment includes primary antibodies and secondary antibodi......
$4950

Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End-User, and Region – Global Forecast to 2025

“Increasing incidence of chronic diseases, and  government investments for cell-based research are set to drive the cell expansion market.’’ The global cell expansion market size is estimated to be USD 14.9 billion in 2020 and projected to reach USD 30.1 billion by 2025, at a CAGR of 15.1%. Growth in this market is largely driven by the increasing incidence of chronic diseases, government investments for cell-based research, growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and increasing GMP certifications for cell therapy production facilities.On the other hand, ethical concerns regarding research in cell biology are expected to limit market growth to a certain extent in the coming years. “By instruments type, the cell expansion ......
$4950

Cell Counting Market by Product (Instruments (Spectrophotometer, Hemocytometer, Flow Cytometer, Hematology Analyzers), Consumables (Reagent, Microplate)), Cancer, Stem Cell Research, End User (Pharmaceutical, Hospital, Research) – Global Forecast to 2025

“The growing funding for cell-based research, rising incidence of chronic and infectious diseases, growing biotechnology and biopharmaceutical industries, and the development of enhanced solutions & improved image analysis will drive market growth.” The global cell counting market is estimated to reach USD 14.5 billion by 2025 from USD 10.4 billion in 2020, at a CAGR of 6.7% during the forecast period. Market growth is largely driven by growing funding for cell-based research, rising incidence of chronic and infectious diseases, growing biotechnology and biopharmaceutical industries, the development of enhanced solutions and improved image analysis, and the growing use of high-throughput flow cytometry and automated hematology analyzers. On the other hand, the high cost of cell ......
$4950

Protein Crystallization & Crystallography Market by Technology (NMR, X-Ray Crystallography), Product & Service (Instrument (Liquid Handling (Automated)), Consumable (Reagent, Microplate) End User, and Region – Global Forecast to 2025

“The increasing adoption of protein-based therapeutics is expected to drive the growth of the protein crystallization and crystallography market.” The global protein crystallization and crystallography market is estimated to grow from USD 1.1 billion in 2020 to USD 1.7 billion by 2025, at a CAGR of 8.9% during the forecast period. The major factors driving the growth of this market include the increasing adoption of protein therapeutics, technological advancements in protein crystallization instruments and consumables, and the increasing focus on miniaturization. “Consumables segment accounted for the largest share of the protein crystallization and crystallography market, by product and service, in 2019.” Based on product and service, the protein crystallization and cryst......
$4950
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy